dc.description.abstract |
Malaria is one of the most common infectious diseases and an enormous public health
problem. The disease is caused by protozoan parasites of the genus Plasmodium and affects
over 100 countries of the tropical and subtropical regions of the world including South-East
Asia, Sub-Saharan Africa and South America. Every year, around 300 to 500 million
clinical cases of malaria are reported, of which nearly 1 to 3 million people, mostly
children, die due to complicated cases of malaria. As per an estimate, every 30 seconds a
child dies of malaria. Malaria is commonly associated with poverty, but is also a cause of
poverty and hence an economic burden on the affected countries. The situation is getting
worse with the emergence and spread of multidrug-resistant parasites.
Four identified species of the Plasmodium parasite responsible for human malaria are
Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. Of these, P. falciparum and P.
vivax account for more than 95% of malaria cases in the world. The female anopheles
mosquito is a vector for transmitting malaria parasites.
Malaria is reemerging as the biggest infectious killer and is currently the first priority
tropical disease of the WHO (World Health Organization). The widespread development of
resistance by P. falciparum to chloroquine, the cheapest, efficacious and most widely used
drug, has posed a major challenge to combat malaria. Artemisinin, isolated from Artemisia
annua and its semisynthetic derivatives e.g. artemether, arteether, and artesunic acid are the
only class of antimalarials, which are effective against multidrug-resistant malaria. The
peroxide bond in the form of 1,2,4-trioxane is essential for the antimalarial activity of this
class of drugs. Ever since the isolation of artemisinin and establishment of the peroxide
bond as its active pharmacophore, synthesis and antimalarial assessment of structurally
simple 1,2,4-trioxanes has become an area of hot pursuit.
The thesis entitled “Structurally Simple Synthetic Peroxides: Synthesis and
Antimalarial Assessment” describes a part of our efforts for developing organic peroxides
as newer antimalarial agents. The thesis has been organized under five main chapters as
summarized below:
The first chapter presents a concise review that accommodates some of the most
significant historical achievements and developments observed in the discovery of
antimalarial drugs, with particular emphasis on the last 35 years. The second chapter describes synthesis and antimalarial activity of novel aminofunctionalized
1,2,4-trioxanes in search for an analog, better than β-arteether.
The third chapter of the thesis describes synthesis and antimalarial activity of novel
lipophilic ether- and ester-functionalized 1,2,4-trioxanes and hydrophilic hemisuccinate
derivatives.
The fourth chapter deals with synthesis and antimalarial assessment of novel nitrogencontaining
peroxides having entirely different pharmacophore than 1,2,4-trioxanes.
The fifth chapter describes synthesis and antimalarial assessment of novel
dihydroartemisinin derivatives, which include dihydroartemisinin derived esters and
hetero-dimers. |
en |